HKPD stock Statistics — Cellyan Biotechnology Co., Ltd filings, insiders & smart money

Beta: Sign in
Shares outstandingAs of 2026-03-31 · filed common shares: 16.34M
Shares float: Sign in
Float %: Sign in
Insider ownership: —
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 1.22%
Short ratioDays to cover, as published by FINRA: 1.82
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 41.00%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 35.70%
Avg volume (10D)

Source: SEC filings. Information and analytics, not investment advice.

Sign in

Avg volume (3 months)

Gross marginFY Mar 26: 10.32%
Operating marginFY Mar 26: -17.77%
Net margin: —
EBITDA marginFY Mar 26: -17.18%
Return on equityNet income (FY Mar 26) ÷ average shareholders equity: -15.54%
Return on assetsNet income (FY Mar 26) ÷ average total assets: -10.21%

Sign in

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, FY Mar 26

-0.06

EPS (fwd)

Cash & equivalentsas of Mar 26: $221.84K
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Mar 26: $1.25M
Debt / equityas of Mar 26: 13.07%
Current ratioas of Mar 26: 3.86
Quick ratio: —
Operating cash flowFY Mar 26: -$751.60K
Free cash flowUnadjusted FCF = CFO − capex · FY Mar 26: -$787.07K
TTM revenue / diluted shareDiluted, FY Mar 26: 0.82